Platelet DNA enhances liquid biopsies for early and residual cancer detection
Dr. Lauren Murphy at the University of Oxford is investigating how platelets could hold the key to detecting cancer in patients with minimal residual disease
Dr. Lauren Murphy at the University of Oxford is investigating how platelets could hold the key to detecting cancer in patients with minimal residual disease
New proof-of-concept study of a direct-from-blood application to accelerate sepsis diagnostic workflows
Learn about the future of newborn screening in this guest editorial from Clinical and Laboratory Standards Institute
Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies
Multiple NHS trusts within South West London Pathology chose HALO AP and Leica Biosystems Aperio GT 450 DX for their digital pathology solutions
The U.S. Food and Drug Administration has approved CytoCell KMT2A Breakapart FISH Probe Kit PDx from OGT
OGT brings clinical genomics experience to develop leading hybridization-based NGS technology delivering the insights clinical research laboratories need, every time
Adding the Accellix platform to the CD-Chex Plus (RUO) control gives platform users a dependable way to monitor performance and maintain confidence in their results
Guest editorial by Courtney Noah, Ph.D., and Daryl Waggott, MSc
Partnerships with PinPoint Testing LLC, RECIPE Chemicals + Instruments GmbH and biocrates life sciences ag highlight assays and turnkey DART MS/MS solutions on the EVOQ® DART-TQ⁺
Roche's achievement marks an important step in broadening the clinical utility of mass spectrometry testing across routine labs
Nine new component allergens are now available, including six specifically targeting peanuts
Learn why the clinical lab plays an important role in antibiotic stewardship programs and sepsis care in this cross-departmental discussion between pharmacy, lab, and critical patient care providers
In sepsis, the delay of even one hour in diagnosis can mean the difference between life and death. What if a standard blood test powered by AI, could flag the risk before symptoms even appear?
Synergistic combination of ctDNA and ISET CTC-DNA improves tumor heterogeneity analysis and diagnostic accuracy
DNA-free nucleic acid isolation kits streamline molecular diagnostics, improving sensitivity, speed, and automation for early diagnosis and monitoring
Multiplex autoantibody test for MPO, PR3, and GBM designed to accelerate diagnosis of autoimmune vasculitis and Goodpasture’s disease
Accuracy in ESR1 mutation testing means the difference between treatment and resistance — now a new ESR1 control kit ensures reliable results
Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast
AISight Dx now supports VENTANA DP 200 and DP 600 slide scanners for pathology laboratories
New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific